+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pantoprazole"

Proton Pump Inhibitors Market Report 2025 - Product Thumbnail Image

Proton Pump Inhibitors Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Gastric Ulcers Market Report 2025 - Product Thumbnail Image

Gastric Ulcers Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Duodenal Ulcer Treatment Market Report 2025 - Product Thumbnail Image

Duodenal Ulcer Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Gastroesophageal Reflux Disease (GERD) Market Report 2025 - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Zollinger-Ellison Syndrome Treatment Market Report 2025 - Product Thumbnail Image

Zollinger-Ellison Syndrome Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Antacids Market Report 2025 - Product Thumbnail Image

Antacids Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
From
From
  • 16 Results (Page 1 of 1)
Loading Indicator

Pantoprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. It is also used to reduce the risk of stomach ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Pantoprazole works by decreasing the amount of acid produced in the stomach. Pantoprazole is available in both prescription and over-the-counter forms. It is available as a tablet, capsule, and powder for suspension. It is also available in combination with other medications, such as amoxicillin and clarithromycin, for the treatment of Helicobacter pylori infection. The Pantoprazole market is a part of the larger Gastrointestinal Drugs market. This market includes a variety of drugs used to treat gastrointestinal disorders, such as antacids, proton pump inhibitors, H2 receptor antagonists, and prokinetics. These drugs are used to treat a wide range of gastrointestinal disorders, including GERD, peptic ulcer disease, irritable bowel syndrome, and inflammatory bowel disease. Some companies in the Pantoprazole market include AstraZeneca, Pfizer, Takeda Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more